Role of clobazam in the treatment of epilepsies

References

• Barzaghi F, Fournex R, Mantegazza P. Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent. Arzneimittelforschung 23, 683–686 (1973).
   Google Scholar
• Dalby MA. Clobazam. In: The Treatment of Epilepsy Shorvon S, Dreifuss F, Fish D, Thomas D (Eds). Blackwell Science, London, UK, 373–377 (1996).
   Google Scholar
• Canadian Clobazam Co-operative Group. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 32, 407–416 (1991).
   PubMed Web of Science ®Google Scholar
• Canadian Study Group for Childhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 39, 952–959 (1998).
   PubMed Web of Science ®Google Scholar
• ••Randomized study that provides evidencethat clobazam should be considered as a first-line monotherapy, along with carbarnazepine and phenytoin for all partial and selected generalized childhood epilepsies.
   Google Scholar
• Koeppen D, Baruzzi A, Capozza M eta]. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study. Epilepsia 28, 495–506 (1987).
   PubMed Web of Science ®Google Scholar
• •Double-blind placebo controlled study that gives evidence of the therapeutical value of clobazam as add-on therapy in refractory epilepsy.
   Google Scholar
• Schmidt D, Rohde M, Wolf P, Roeder- Wanner U. Clobazam for refractory focalepilepsy. A controlled trial. Arch. Neural. 43, 824–826 (1986).
   Google Scholar
• •Double-blind add-on trial in patients with refractory complex partial seizures that shows that clobazam is an effective add-on drug.
   Google Scholar
• Schmidt D. Clobazam for treatment of intractable epilepsy: a critical assessment. Epilepsia 35 (Suppl. 5), S92—S95 (1994).
   Google Scholar
• Remy C. Clobazam in the treatment of epilepsy: a review of the literature. Epilepsia 35 (Suppl. 5), S88—S91 (1994).
   Google Scholar
• •Excellent review.
   Google Scholar
• Buchanan N. Clobazam in the treatment of epilepsy: prospective follow-up to 8 years. JR Soc. Med. 86, 378–380 (1993).
   Google Scholar
• Montenegro MA, Cendes F, Noronha AL et al. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy. Epilepsia 42, 539–542 (2001).
   PubMed Web of Science ®Google Scholar
• Barcs G, Halasz P Effectiveness and tolerance of clobazam in temporal lobe epilepsy. Acta. Neural. Land. 93, 88–93 (1996).
   PubMed Web of Science ®Google Scholar
• Singh A, Guberman AH, Boisvert D. Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance. Epilepsia 36, 798–803 (1995).
   PubMed Web of Science ®Google Scholar
• Keene DL, Whiting S, Humphreys P Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood. Can. J Neural Sc]. 17, 317–319 (1990).
   PubMed Web of Science ®Google Scholar
• Guberman A, Couture M, Blaschuk K, Sherwin A. Add-on trial of clobazam in intractable adult epilepsy with plasma level correlations. Can.j Neural Sc]. 17, 311–316 (1990).
   PubMed Web of Science ®Google Scholar
• Reynolds EH, Heller AJ, Ring HA. Clobazam for epilepsy. Lancet 2, 565 (1988).
   Google Scholar
• Heller AJ, Ring HA, Reynolds EH. Factors relating to dramatic response to clobazam therapy in refractory epilepsy. Epilepsy Res. 2, 276–280 (1988).
   Google Scholar
• Scott DF, Moffett A. The long-term effect of clobazam as adjunctive therapy in epilepsy. Acta. Neural Land. 77, 498–502 (1988).
   PubMed Web of Science ®Google Scholar
• Allen JW, Oxley J, Robertson MM, Trimble MR, Richens A, Jawad SS. Clobazam as adjunctive treatment in refractory epilepsy. BE Med. J. 286, 1246–1247 (1983).
   PubMed Web of Science ®Google Scholar
• Heller AJ, Ring HA, Reynolds EH. Clobazam for refractory epilepsy. Arch. Nemo'. 44, 578 (1987).
   Google Scholar
• Satishchandra P, Varadarajalu R, Rajaram Long-term use of clobazam in the management of intractable epilepsy: a prospective study. Neumlogy 46, 284–287 (1998).
   Web of Science ®Google Scholar
• Gastaut H, Low MD. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man. Epilepsia 20, 437–446 (1979).
   PubMed Web of Science ®Google Scholar
• Jawad S, Richens A, Oxley J. Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br.Clin. Pharmacol 18, 873–877(1984).
   Google Scholar
• Anderson GD, Miller JW. Benzodiazepines. Chemistry, Biotransformation and Pharmacokinetics. In: Antiepileptic Drugs. Fifth Edition. Levy RII, Mattson RII, Meldrum BS, Perucca E(Eds). Lippincott Williams & Wilkins, PA, USA, 187–205 (2002).
   Google Scholar
• Borel AG, Abbott FS. Metabolic profiling of clobazam, a 1,5-benzodiazepine, in rats. Drug Metab. Disp. Biol. Fate Chem. 21, 415–441 (1993).
   Google Scholar
• WIZ M, Christ 0, Kellner HM et al Kinetics and metabolism of clobazam in animals and man. BE j Clin. Phatmacol 7\(Suppl. 1) 41–50 (1979).
   Google Scholar
• Shorvon SD. Benzodiazepines. Clobazam. In: Antiepileptic Drugs. Fourth Edition. Levy RII, Mattson RII, Meldrum BS (Eds).Raven Press Ltd., NY, USA, 763–777 (1995).
   Google Scholar
• Callaghan N, Gogin T Clobazam as adjunctive treatment in drug-resistant epilepsy: report on an open prospective study. .5: Med 77, 240–244 (1994).
   Google Scholar
• Haigh JR, Pullar T, Gent JP, Dailley C, Feely M. N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? BE j Clin. Pharmacol 23, 213–218 (1987).
   Web of Science ®Google Scholar
• McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod. Toxical 8, 461–475 (1994).
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Nulman I, Koren G, Ito S. Anticonvulsants and breast-feeding: a critical review. Paecliatc Drugs 2, 113–126 (2000).
   PubMedGoogle Scholar
• Munoz JJ, De Salamanca RE, Diaz- Obregon C, Timoneda FL. The effect of clobazam on steady-state plasma concentrations of carbamazepine and its metabolites. BE j Clin. Pharmacol 29, 763–765 (1990).
   Google Scholar
• Zifkin B, Sherwin A, Andermann F. Phenytoin toxicity due to interaction with clobazam. Neurology 41, 313–314 (1991).
   Google Scholar
• Schmidt D. Benzodiazepines. Clinical efficacy and use in epilepsy. In: Antiepileptic Drugs. Fifth Edition. Levy RII, Mattson RII, Meldrum BS, Perucca E (Eds). Lippincott Williams & Wilkins, PA, USA, 206–213 (2002).
   Google Scholar
• Dulac O, Figueroa D, Rey E, Arthuis M. Monotherapy with clobazam in epilepsies inchildren. Prase Med 12, 1067–1069 (1983).
   PubMed Web of Science ®Google Scholar
• Trimble MR. On the use of tranquillisers in epilepsy. Epilepsia 43\(Suppl. 2), 25–27 (2002).
   Google Scholar
• •Excellent review.
   Google Scholar
• Trimble MR, Thompson PJ. Anticonvulsant drugs, cognitive function and behavior. Epilepsia 24\(Suppl. 1), S55—S63 (1983).
   Google Scholar
• Bourgeois BFD. Phenobarbital and primidone. In: The Treatment of Epilepy: Principles and Practice. Wyllie E (Ed.). Williams & Wilkins, MD, USA, 845–855 (1997).
   Google Scholar
• Hyson C, Sadler M. Cross sensitivity of skin rashes with anti-epileptic drugs. Can. .1. Neural Sci. 24,245-249 (1997).
   Google Scholar
• Dulac O. Epileptic encephalopathy. Epilepsia 42\(Suppl. 3), 23–26 (2001).
   Google Scholar
• Thanh TN, Chiron C, Dellatolas G eta]. Long-term efficacy and tolerance of stiripentaol in severe myoclonic epilepsy of infancy (Dravet's syndrome). Arch. Pecliatc 9,1120–1127 (2002).
   Google Scholar
• Schmidt D, Bourgeois B. A risk—benefit assessment of therapies for Lennox—Gastaut syndrome. Drug- Safety22,467–477 (2000).
   PubMed Web of Science ®Google Scholar
• Bawden HN, Camfield CS, Camfield PR eta]. The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy. Epilepsy Res. 33, 133–143 (1999).
   Google Scholar
• Sheth RD, Ronen GM, Goulden KJ, Penney S, Bodensteiner JB. Clobazam for intractable pediatric epilepsy. j Child. Neural 10,205–208 (1995).
   Google Scholar
• Munn R, Farrell K. Open study of clobazam in refractory epilepsy. Pecliatc Neural 9,465–469 (1993).
   PubMed Web of Science ®Google Scholar
• De Sarro G, Di Paola ED, Aguglia U, de Sarro A. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats. Pharmacol Biochem. Behav. 55,39–48 (1996).
   PubMed Web of Science ®Google Scholar
• Wildin JD, Pleuvry BJ. Tolerance to the anticonvulsant effects of clobazam in mice. Neuropharmacology31, 129–135 (1992).
   PubMed Web of Science ®Google Scholar
• Shimizu H, Kawasaki J, Yuasa S, Tarao Y, Kumagai S, Kanemoto K. Use of clobazam for the treatment of refractory complex partial seizures. Seizure 12,282–2826 (2003).
   PubMed Web of Science ®Google Scholar
• Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 2,71–73 (1982).
   Google Scholar
• Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. .1. Nemo'. Neurosurg. Psychiatry47, 1279–1282 (1984).
   Google Scholar
• Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents and young adults: etiology, outcome and treatment. Epilepsia 37\(Suppl. 1), S74—S80 (1996).
   Google Scholar
• Haut, S R, Shinnar S, Moshé SL, O'Dell C, Legatt AD. The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures. Epilepsia 40,1832–1834 (1999).
   Google Scholar
• Tinuper P, Aguglia U, Gastaut H. Use of clobazam in certain forms of status epilepticus and in startle-induced epileptic seizures. Epilepsia 27\(Suppl. 1), S18—S26 (1986).
   Google Scholar
• Corman C, Guberman A, Benavente O. Clobazam in partial status epilepticus. Seizure 7,243–247 (1998).
   Google Scholar
• Larrieu JL, Lagueny A, Ferrer X, Julien J. Epilepsy with continuous discharges during slow-wave sleep. Treatment with clobazam. Rev. Dectroencephalogr: Neurophysiol Clin. 16,383-394 (1986).
   Google Scholar
• Kobayashi K, Nishibayashi N, Ohtsuka Y, Oka E, Ohtahara S. Epilepsy with electrical status epilepticus during slow sleep and secondary bilateral synchrony. Epilepsia 35, 1097–1103 (1994).
   Google Scholar
• Tondi M, Carboni F, Deriu A, Manca S, Mastropaolo C. Intermittent therepy with clobazam for simple febrile convulsions. Dev. Med. Child. Neural 19,830–835 (1987).
   Google Scholar
• Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsivant hypersensitivity syndrome. Neurology 55, 1172–1175 (1998).
   Google Scholar
• Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 39\(Suppl. 7), S3—S7 (1998).
   Google Scholar
• Shear NH, Spielberg SR Anticonvulsant hypersensibility syndrome: in vitro assessment of risk. j Clin. Invest. 82, 1826–1832 (1988).
   PubMed Web of Science ®Google Scholar
• Moss DM, Rudis M, Henderson SO. Cross-sensitivity and the antiepileptic hypersensitivity syndrome. I Emerg: Med. 17,503–506 (1999).
   Google Scholar